Results of a phase II study of 506U78 in cutaneous T-cell lymphoma and peripheral T-cell lymphoma: CALGB 59901.
- Citation:
- Leuk Lymphoma vol 48 (1) 97-103
- Year:
- 2007
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- CA02599, CA04326, CA11789, CA31946, CA33601, CA35113, CA41287, CA47577, CA77406, CA77440, CA77658
- Corr. Author:
- Authors:
- Myron S Czuczman Pierluigi Porcu Jeffrey Johnson Donna Niedzwiecki Michael Kelly Eric D Hsi James R Cook George Canellos Bruce D Cheson
- Networks:
- Study
- CALGB-59901
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Adult, Aged, Antineoplastic Agents, Arabinonucleosides, Disease-Free Survival, Female, Humans, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Male, Middle Aged, Prodrugs, Survival Analysis, Treatment Outcome